https://pharmatimes.com in-depth news, features and insights for the pharmaceutical and healthcare sectors Mon, 20 Jul 2026 09:06:35 +0000 en-US hourly 1 https://pharmatimes.com/wp-content/uploads/2023/11/PT-icon-150x150.png https://pharmatimes.com 32 32 232894315 https://pharmatimes.com/appointments/ariane-de-ganck/ Mon, 20 Jul 2026 09:05:50 +0000 https://pharmatimes.com/?p=104835 Ardena has appointed Ariane de Ganck as Chief Scientific Officer

]]> 104835 https://pharmatimes.com/news/jasper-therapeutics-merges-with-kira-pharmaceuticals/ Mon, 20 Jul 2026 08:57:43 +0000 https://pharmatimes.com/?p=104833 Combined company to advance biologics for immunologically‑driven disorders

]]> 104833 https://pharmatimes.com/appointments/bethany-mancilla/ Thu, 16 Jul 2026 12:45:48 +0000 https://pharmatimes.com/?p=104830 Latus Bio has appointed Bethany Mancilla as Chief Business Officer

]]> 104830 https://pharmatimes.com/news/epilepsygtx-and-clearpoint-neuro-join-forces-on-targeted-therapy/ Thu, 16 Jul 2026 12:37:56 +0000 https://pharmatimes.com/?p=104828 Partnership to support first‑in‑human trial of EPY201 in epilepsy

]]> 104828 https://pharmatimes.com/appointments/sophie-spencer/ Wed, 15 Jul 2026 12:52:28 +0000 https://pharmatimes.com/?p=104821 B. Braun has appointed Sophie Spencer as Social Value & ESG Specialist

]]> 104821 https://pharmatimes.com/news/nice-backs-finerenone-for-heart-failure/ Wed, 15 Jul 2026 12:36:59 +0000 https://pharmatimes.com/?p=104819 Guidance expands treatment options for patients

]]> 104819 https://pharmatimes.com/news/ec-approves-erbitux-combination-for-first-line-treatment-of-braf-v600e-mutant-mcrc/ Tue, 14 Jul 2026 10:52:57 +0000 https://pharmatimes.com/?p=104816 Breakwater data show significant survival gains over standard chemotherapy

]]> 104816 https://pharmatimes.com/news/fda-approves-leqembi-iqlik-subcutaneous-initiation-dose-for-alzheimers-disease/ Tue, 14 Jul 2026 10:39:42 +0000 https://pharmatimes.com/?p=104814 At‑home autoinjector option offers new flexibility for patients and care partners

]]> 104814 https://pharmatimes.com/news/smc-recommends-veoza-for-moderate-to-severe-menopausal-vasomotor-symptoms/ Mon, 13 Jul 2026 12:07:50 +0000 https://pharmatimes.com/?p=104811 Non-hormonal option to be made available for patients unsuitable for HRT

]]> 104811 https://pharmatimes.com/news/smc-backs-columvi-combination-for-second-line-lymphoma-treatment-in-scotland/ Mon, 13 Jul 2026 12:02:47 +0000 https://pharmatimes.com/?p=104809 Roche therapy accepted for adults ineligible for stem cell transplant

]]> 104809